Trend and momentum on Vertex Pharmaceuticals Incorporated (VRTX): a 10-year backtest

From Nov 21, 2016 to Nov 19, 2026, the Trend and momentum rule returned 27% on VRTX, against 478% for buying and holding VRTX over the same days.

Its worst drop was -51%, against -42% for holding.

The rule made 26 trades, and 15% of them made money.

The rule: Steps in when RSI(14) crosses above 50 while the price is above its 200-day average, and steps out when the close drops below that average. Enters when Price (close) is greater than SMA(200) and RSI(14) crosses above 50. Exits when Price (close) crosses below SMA(200).

Run unchanged on 140 large US stocks from a fixed list, the Trend and momentum rule beat buying and holding on 27 and did not on 113. Its worst drop was smaller than holding's on 109 of them.

Figures as of November 20, 2026. The live ones load with the page.

Other rules on VRTX: Golden cross (139% vs 478% for holding) · RSI pullback (27% vs 478% for holding) · Bollinger Band reversion (282% vs 478% for holding) · MACD crossover (-35% vs 478% for holding) · Donchian breakout (-58% vs 478% for holding) · 200-day line (58% vs 478% for holding) · Golden cross with a 10% stop (117% vs 478% for holding) · Take profit at 20% (363% vs 478% for holding)

The Trend and momentum rule on other stocks: MRNA (1748% vs 1044% for holding) · WMT (90% vs 484% for holding) · COST (155% vs 670% for holding) · HD (31% vs 215% for holding) · LOW (-11% vs 262% for holding) · TGT (212% vs 166% for holding) · NKE (-18% vs -9.7% for holding) · SBUX (-5.9% vs 122% for holding)

Each rule is a textbook example, run unchanged over the last ten years of stored daily prices. The rule and buying and holding start with the same cash and pay the same commission and slippage, before taxes. The stocks are a fixed list of large US companies, picked by size and not by how any rule did on them.

Hypothetical results from past prices. They do not reflect real trading, and past results do not predict future results. Nothing here is investment advice.

Data provided by Twelve Data.

Trend and momentum: every stock · Every rule · Test a rule on any stock · Rexius Finance home